Pharming (PHAR) Change in Acquisitions & Divestments (2023 - 2026)

Pharming (PHAR) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $85.0 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 72.98% year-over-year to $85.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $660.5 million (up 35.31% YoY) and the FY2025 annual result came in at $85.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments slipped to $85.0 million in Q4 2025, from $314.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $314.6 million in Q4 2024 to a low of -$87.3 million in Q2 2023.
• A 3-year average of $114.6 million and a median of $114.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments surged 114.97% — and 2025, when it slumped 72.98%.
• Tracing PHAR's Change in Acquisitions & Divestments over 3 years: stood at $146.4 million in 2023, then soared by 114.97% to $314.6 million in 2024, then sank by 72.98% to $85.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $85.0 million (Q4 2025), $314.6 million (Q4 2024), and $114.5 million (Q3 2024), per Business Quant data.